BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3885020)

  • 21. The effect of quercetin on the mutagenicity of 2-acetylaminofluorene and benzo[alpha]pyrene in Salmonella typhimurium strains.
    Ogawa S; Hirayama T; Nohara M; Tokuda M; Hirai K; Fukui S
    Mutat Res; 1985 Mar; 142(3):103-7. PubMed ID: 3919287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biotransformation of genotoxic agents in marine sponges. Mechanisms and modulation.
    De Flora S; Bagnasco M; Bennicelli C; Camoirano A; Bojnemirski A; Kurelec B
    Mutagenesis; 1995 Jul; 10(4):357-64. PubMed ID: 7476273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of benzo[a]pyrene and 2-aminoanthracene to bacteria mutagens by mussel digestive gland postmitochondrial fraction.
    Michel XR; Cassand PM; Narbonne JF
    Mutat Res; 1993 Feb; 301(2):113-9. PubMed ID: 7678168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation and detoxication of promutagens by toadfish (Opsanus tau) hepatic postmitochondrial fractions in the Salmonella assay.
    Milling DM; Maddock MB
    Mutat Res; 1986 Apr; 164(2):81-9. PubMed ID: 3515163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of the potency of promutagens and direct acting mutagens in bacteria by inhibitors of the multidrug resistance mechanism.
    De Flora S; Camoirano A; Cartiglia C; Ferguson L
    Mutagenesis; 1997 Nov; 12(6):431-5. PubMed ID: 9412996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-mutagenic activity of Phyllanthus amarus Schum & Thonn in vitro as well as in vivo.
    Raphael KR; Ajith TA; Joseph S; Kuttan R
    Teratog Carcinog Mutagen; 2002; 22(4):285-91. PubMed ID: 12111712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of vitamins A, C and glutathione on the mutagenicity of benzo[a]pyrene mediated by S9 from vitamin A-deficient rats.
    Alzieu P; Cassand P; Colin C; Grolier P; Narbonne JF
    Mutat Res; 1987 Dec; 192(4):227-31. PubMed ID: 2446127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excretion of 3-hydroxy-benzo(a)pyrene and mutagenicity in rat urine after exposure to benzo(a)pyrene.
    Jongeneelen FJ; Leijdekkers CM; Bos RP; Theuws JL; Henderson PT
    J Appl Toxicol; 1985 Oct; 5(5):277-82. PubMed ID: 3902943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutagenicity of pyrene in Salmonella.
    Matijasević Z; Zeiger E
    Mutat Res; 1985 Apr; 142(4):149-52. PubMed ID: 3885017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutagenic activation of aromatic amines by a human hepatoma cell (Hep G2) supernatant tested by means of Salmonella typhimurium strains with different acetyltransferase activities.
    Duverger-van Bogaert M; Dierickx PJ; Crutzen MC
    Mutat Res; 1995 Dec; 335(3):219-27. PubMed ID: 8524336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of age on the ability of rat liver tissues to transform chemical promutagens to mutagens.
    Hilali A; Crutzen-Fayt MC; Gerber GB; Léonard A
    Gerontology; 1993; 39(3):125-7. PubMed ID: 8406054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential pitfalls associated with testing of enzyme preparations in the Salmonella/microsome assay.
    Conti L; Crebelli R
    Regul Toxicol Pharmacol; 2016 Oct; 80():291-4. PubMed ID: 27330008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of promutagens by liver homogenates isolated from female mice at different ages; lack of significant differences.
    Guttenplan JB; Bliznakov EG
    Mech Ageing Dev; 1981 May; 16(1):29-35. PubMed ID: 6265715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds.
    De Flora S; Bennicelli C; Camoirano A; Serra D; Romano M; Rossi GA; Morelli A; De Flora A
    Carcinogenesis; 1985 Dec; 6(12):1735-45. PubMed ID: 3905042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of some aromatic amines to mutagenic products by human red blood cell cytosol.
    Duverger-van Bogaert M; Crutzen-Fayt MC; Stecca C
    Mutat Res; 1991 Aug; 263(4):249-55. PubMed ID: 1861690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimum S9 concentrations in bacterial mutagenicity assays.
    Forster R; Green MH; Priestley A
    Adv Exp Med Biol; 1981; 136 Pt B():1263-9. PubMed ID: 7046386
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of Aroclor 1254 dose upon S9 activation of aromatic amine bacterial mutagens.
    Thompson CZ; Whitaker GW; McMahon RE
    Mutat Res; 1980 Apr; 77(4):361-6. PubMed ID: 6769038
    [No Abstract]   [Full Text] [Related]  

  • 38. Reversal of sodium-azide mutagenicity by liver preparations and by gastric juice.
    de Flora S; Coppola R; Zanacchi P; Bennicelli C
    Mutat Res; 1979 Jul; 61(2):387-92. PubMed ID: 384225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism and mutagenicity of aromatic amines by human fetal liver.
    Aune T; Haugen A; Dybing E
    Arch Toxicol; 1985 Jun; 57(2):136-8. PubMed ID: 4026573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutagenicity of methylated fluorenes and benzofluorenes.
    Lavoie EJ; Tulley L; Bedenko V; Hoffmann D
    Mutat Res; 1981 May; 91(3):167-76. PubMed ID: 7017394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.